Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...
California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.
The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...
The state-branded, life-saving drugs for some 3.5 million Californians with diabetes will be much cheaper, the governor ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback